[Form 4] ALLSTATE CORP Insider Trading Activity

Rhea-AI Filing Summary

The Allstate Corporation’s Chairman, President & CEO Thomas J. Wilson reported multiple open-market sales of company common stock on January 12, 2026. Across several trades coded as sales, he sold a total of 16,807 shares at weighted average prices ranging from $205.6779 to $209.9939, with actual sale prices spanning from $205.30 to $210.42.

The filing notes that these transactions were carried out under a Rule 10b5-1 trading plan adopted on June 27, 2025, indicating they were pre-arranged. Following the reported sales, Wilson directly beneficially owns 94,408.303 shares of Allstate common stock. He also reports indirect holdings, including 31,900 shares held by a 2024-C GRAT and 69,822 shares held by a 2025-A GRAT, along with additional trust and plan positions.

Insights

Equity analyst

Allstate’s CEO executes pre-planned stock sales while retaining sizable direct and indirect holdings.

Thomas J. Wilson, Chairman, President & CEO of Allstate, reported open-market sales totaling 16,807 shares of common stock on January 12, 2026. The trades occurred in several blocks at weighted average prices between $205.6779 and $209.9939, with individual prices ranging from $205.30 to $210.42. These are routine Form 4-coded sales rather than option exercises or derivative transactions.

The disclosure states that the sale transactions were effected under a Rule 10b5-1 trading plan adopted on June 27, 2025. Such plans are designed to allow executives to sell shares according to a preset schedule, which can reduce concerns that sales are timed around undisclosed information. After the sales, Wilson directly beneficially owns 94,408.303 Allstate shares, indicating continued direct exposure to the company’s equity.

In addition to direct ownership, Wilson reports indirect interests through various estate-planning and retirement vehicles, including 31,900 shares held by a 2024-C GRAT, 69,822 shares by a 2025-A GRAT, 94,729 shares by a 2025-E GRAT, and positions in a 2020 GRAT remainder trust and a 401(k) plan. Subsequent company filings will indicate any future transactions under this Rule 10b5-1 plan or changes in these holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON THOMAS J

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062-7154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2026		S		4,785	D	$205.6779(1)	106,430.303(2)	D
Common Stock	01/12/2026		S		1,551	D	$207.0221(3)	104,879.303(2)	D
Common Stock	01/12/2026		S		4,322	D	$208.3543(4)	100,557.303(2)	D
Common Stock	01/12/2026		S		4,428	D	$209.0673(5)	96,129.303(2)	D
Common Stock	01/12/2026		S		1,721	D	$209.9939(6)	94,408.303(2)	D
Common Stock								31,900	I	By 2024-C GRAT
Common Stock								69,822	I	By 2025-A GRAT
Common Stock								94,729	I	By 2025-E GRAT
Common Stock								324,088	I	By 2020 GRAT Remainder Trust
Common Stock								7,681	I	By 401(k) Plan
Common Stock								257,535	I	Remainder GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $205.30 to $206.055. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

2. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.

3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $206.435 to $207.350. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.58 to $208.55. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

5. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.59 to $209.57. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

6. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $209.60 to $210.42. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

	/s/ Thomas J. Wilson	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.